Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1990-03-22
1991-03-12
Bond, Robert T.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
530317, 540460, 435121, 4352531, 435886, 43525235, C12P 1712, A61K 31395, C07D25502, C07K 512, C12N 120
Patent
active
049993496
ABSTRACT:
Disclosed herein are antibiotic BU-4164E A and B isolated from Streptomyces sp. These compounds are prolyl endopeptidase inhibitors.
REFERENCES:
patent: 4701465 (1987-10-01), Tanaka et al.
patent: 4743616 (1988-05-01), Tanaka et al.
patent: 4757083 (1988-07-01), Higuchi et al.
patent: 4772587 (1988-09-01), Tanaka et al.
patent: 4810721 (1989-03-01), Saitoh et al.
patent: 4826870 (1989-05-01), Higuchi et al.
patent: 4857524 (1989-08-01), Furukawa et al.
patent: 4857537 (1989-08-01), Toda et al.
patent: 4898940 (1990-02-01), Konishi et al.
Hamagishi Yasutaro
Oki Toshikazu
Toda Soichiro
Tomita Koji
Bond Robert T.
Bristol-Myers Squibb Co.
Cepeda Michelle A.
LandOfFree
BU-4164E - A and B, prolyl endopeptidase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with BU-4164E - A and B, prolyl endopeptidase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and BU-4164E - A and B, prolyl endopeptidase inhibitors will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-448717